Menzo J. Havenga

Bioscience Park Leiden, Zernikedreef 16
Leiden, ZH 2333CL, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Sabin inactivated polio vaccine upstream process development using fixed-bed bioreactor technology.

Sabin inactivated polio vaccine upstream process development using fixed-bed bioreactor technology.

Journal: Vaccine

Published: December 16, 2024

High throughput AS LNA qPCR method for the detection of a specific mutation in poliovirus vaccine strains.

High throughput AS LNA qPCR method for the detection of a specific mutation in poliovirus vaccine strains.

Journal: Vaccine

Published: September 13, 2023

Human AdV-20-42-42, a Promising Novel Adenoviral Vector for Gene Therapy and Vaccine Product Development.

Human AdV-20-42-42, a Promising Novel Adenoviral Vector for Gene Therapy and Vaccine Product Development.

Journal: Journal of virology

Published: September 01, 2021

Stable, high yield expression of gp145 Env glycoprotein from HIV-1 in mammalian cells.

Stable, high yield expression of gp145 Env glycoprotein from HIV-1 in mammalian cells.

Journal: Biologicals : journal of the International Association of Biological Standardization

Published: February 22, 2021

STEP® vectors for rapid generation of stable transfected CHO cell pools and clones with high expression levels and product quality homogeneity of difficult-to-express proteins.

STEP® vectors for rapid generation of stable transfected CHO cell pools and clones with high expression levels and product quality homogeneity of difficult-to-express proteins.

Journal: Protein expression and purification

Published: January 22, 2021

Human species D adenovirus hexon capsid protein mediates cell entry through a direct interaction with CD46.

Human species D adenovirus hexon capsid protein mediates cell entry through a direct interaction with CD46.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: January 01, 2021

Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccine.

Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccine.

Journal: Vaccine

Published: October 02, 2020

A microbial expression system for high-level production of scFv HIV-neutralizing antibody fragments in Escherichia coli.

A microbial expression system for high-level production of scFv HIV-neutralizing antibody fragments in Escherichia coli.

Journal: Applied microbiology and biotechnology

Published: June 15, 2019

Ex Vivo Expansion of Hematopoietic Stem Cells for Therapeutic Purposes: Lessons from Development and the Niche.

Ex Vivo Expansion of Hematopoietic Stem Cells for Therapeutic Purposes: Lessons from Development and the Niche.

Journal: Cells

Published: December 28, 2018

First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1.

First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1.

Journal: PloS one

Published: July 07, 2018

Generation and characterization of a novel candidate gene therapy and vaccination vector based on human species D adenovirus type 56.

Generation and characterization of a novel candidate gene therapy and vaccination vector based on human species D adenovirus type 56.

Journal: The Journal of general virology

Published: November 21, 2017

Enhancing viral vaccine production using engineered knockout vero cell lines - A second look.

Enhancing viral vaccine production using engineered knockout vero cell lines - A second look.

Journal: Vaccine

Published: November 20, 2017

Showing 1-12 of 17

Last Updated: 09/26/2026